CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Oliceridine +1 moredrug
Likely dose
Oliceridine 1mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07372209
NCT07372209N/ACompleted

Study of Effects and Underlying Mechanisms of Analgesic Drugs on Inflammatory Pathways and Immune Function in Patients With Endometrial Cancer

Tangshan Maternal and Child Health Hospital·interventional·Posted Jan 28, 2026·Updated Jan 28, 2026

In Brief

A clinical study evaluating Oliceridine and Sufentanil for Gynecological Laparoscopic Surgery and 2 related conditions. Completed, enrolled 120 participants across 1 site.

Detailed Summary

to investigate whether oliceridine is safe and effective for induction of anesthesia by comparing henodynamic changes before and after endotracheal intubation with sufentanil

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2026
First PostedJan 28, 2026
Enrollment StartOct 1, 2025
Primary CompletionDec 15, 2025
Study CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5 months ago

Interventions

Oliceridinedrug

Oliceridine is diluted to a 1mg/kg injection solution

Sufentanildrug

sufentanil is diluted to a 5μg/ml injection solution